Deflazacort 6mg Tablets

Deflazacort 6mg is an oral corticosteroid used for steroid-responsive inflammatory and immune-mediated conditions. It also has a role in Duchenne muscular dystrophy, where treatment can help preserve muscle function. The strength chosen reflects the condition, treatment phase and individual response, not a different active ingredient.
Take the tablet with water at a consistent time. It can be taken with or without food; breakfast may reduce stomach discomfort when a once-daily morning regimen is used. Avoid grapefruit and grapefruit juice. Longer courses can require a stepwise reduction rather than an abrupt stop.
Deflazacort is converted to an active glucocorticoid metabolite. Activation of glucocorticoid receptors changes inflammatory and immune-related gene expression, reducing inflammatory mediator activity.
Increased appetite, weight gain, indigestion, sleep disturbance, mood changes and raised blood glucose may occur. Prolonged use can cause bone loss, cataracts, adrenal suppression and greater susceptibility to infection. Severe infection, gastrointestinal bleeding or major psychiatric symptoms needs urgent attention.
Tell your doctor about diabetes, hypertension, tuberculosis or other infections, ulcers, glaucoma, osteoporosis, pregnancy and breastfeeding. Live vaccines and medicines such as clarithromycin, azole antifungals and rifampicin need particular attention. During ongoing treatment, blood pressure, glucose, bone health and growth in children may need monitoring.
Reducing inflammation can improve symptoms and function in appropriately selected conditions. In Duchenne muscular dystrophy, sustained treatment may help delay functional decline; it does not replace other aspects of neuromuscular care.
No. It is a glucocorticoid, not an anabolic steroid. Prolonged exposure can itself cause muscle weakness, despite its distinct benefit in selected conditions such as Duchenne muscular dystrophy.
No. Although individual steroid profiles differ, deflazacort can still increase appetite, weight and blood glucose. It should not be described as free of typical systemic steroid effects.
Ongoing steroid treatment can suppress the body's response to physical stress. A temporary change in steroid coverage may be needed during surgery, serious illness or significant injury.
No. The medicines have different potencies. A switch requires a steroid-equivalent calculation and consideration of the previous duration of treatment.
Corticosteroid: a medicine with cortisol-like anti-inflammatory effects. DMD: Duchenne muscular dystrophy, an inherited progressive muscle disorder. Adrenal suppression: reduced natural cortisol production. Glucocorticoid receptor: a cellular receptor that mediates steroid effects; AR: Deflazacort 6mg أقراص; FR: Deflazacort 6mg comprimés; PT: Deflazacort 6mg comprimidos; ES: Deflazacort 6mg comprimidos; RU: Deflazacort 6mg таблетки; ID: Deflazacort 6mg tablet; VI: Deflazacort 6mg viên nén; MS: Deflazacort 6mg tablet; TL: Deflazacort 6mg tableta; ZH-SG: Deflazacort 6mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Deflazacort 6mg Tablets under Steroid Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Deflazacort 6mg Tablets